BMY: Message Board for Bristol-Myers Squibb Co. - InvestorVillage


Bristol-Myers Squibb Co.

  BMY website

BMY   /  Message Board

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
MSG # SUBJECT TYPE AUTHOR SENTIMENT RECS DATE POSTED
8831 Re: Cowen - 20 EVENTS IN 2022 THAT COULD CHANGE PRACTICE, ALTER COMPANIES, MOVE STOCKS GN Doolen 2 1/16/2022 7:58:31 AM
8830 Cowen - 20 EVENTS IN 2022 THAT COULD CHANGE PRACTICE, ALTER COMPANIES, MOVE STOCKS GN JBWIN 16 1/15/2022 4:35:40 PM
8829 Adagene Announces First Patients with Advanced Non-Small Cell Lung Cancer Dosed in Phase 1b/2 Clinical Trial of ADG106 in Combination with Nivolumab in Singapore GN jerrykrause 3 1/15/2022 12:16:17 PM
8828 Re: All indices are in dark red but big pharma are either green or fractional loss! Pricing pressure seems to be absent. GN Biotech2050 3 1/14/2022 11:10:21 AM
8827 All indices are in dark red but big pharma are either green or fractional loss! Pricing pressure seems to be absent. GN teflon2000 1 1/14/2022 10:55:09 AM
8826 Reblozyl article in OncLive GN Biotech2050 8 1/13/2022 6:00:45 AM
8825 Building IP: BMY Patent Application re "SMALL MOLECULE INHIBITORS OF GALECTIN-3" GN JBWIN 2 1/13/2022 12:56:39 AM
8824 Building IP: CELG Patent Application re "3-(4-((4-(MORPHOLINOMETHYL-BENZYL)OXY)-1 -OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS" GN JBWIN 1 1/13/2022 12:54:38 AM
8823 Building IP: Juno Therapeutics Patent Application re "METHODS OF DOSING ENGINEERED T CELLS FOR THE TREATMENT OF B CELL MALIGNANCIES" GN JBWIN 1 1/13/2022 12:52:27 AM
8822 Building IP: Juno Therapeutics Patent Application re "METHODS AND COMBINATIONS FOR TREATMENT AND T CELL MODULATION" GN JBWIN 1 1/13/2022 12:51:11 AM
Previous 2500 Messages Top of Message List Post Message Go to Msg #  


Financial Market Data provided by
.
Loading...